Helen Kim

Demonstrated experience in global business development --Currently leading a team responsible for identifying, evaluating, and transacting innovative technologies that enable drug discovery, including oncology, autoimmune diseases and small and large molecule platform technologies --Business development: development of work plans and deal structure, driving alignment both internally and externally, contract negotiation/transaction --Leading and executing on strategic academic/industry partnerships --Demonstrated leadership and managerial skills Research and management experience in biotechnology, including multi-site management --Exerience in both large and small molecule drug development with special focus in oncology --Building and managing high-performing teams, molecular/cell biology, next-gen-sequencing, genomics, antibody and protein engineering/expression, high-titer cell line development, assay development